.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Teva
Harvard Business School
Baxter
US Army
Queensland Health
Cantor Fitzgerald
Dow
Farmers Insurance
US Department of Justice

Generated: June 23, 2017

DrugPatentWatch Database Preview

MYCOSTATIN Drug Profile

« Back to Dashboard

What is the patent landscape for Mycostatin, and what generic Mycostatin alternatives are available?

Mycostatin is a drug marketed by Bristol Myers Squibb and Delcor Asset Corp and is included in seven NDAs.

The generic ingredient in MYCOSTATIN is nystatin. There are eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the nystatin profile page.

Summary for Tradename: MYCOSTATIN

Patents:0
Applicants:2
NDAs:7
Bulk Api Vendors: see list23
Clinical Trials: see list1
Patent Applications: see list21
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MYCOSTATIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
MYCOSTATIN
nystatin
PASTILLE;ORAL050619-001Apr 9, 1987DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
POWDER;TOPICAL060578-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
TABLET;ORAL060574-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
SUSPENSION;ORAL061533-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Delcor Asset Corp
MYCOSTATIN
nystatin
OINTMENT;TOPICAL060571-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Novartis
Cipla
Harvard Business School
QuintilesIMS
Medtronic
US Department of Justice
Boehringer Ingelheim
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot